Breaking News

AMRI, CAS Ink SciFinder Agreement

CDMO commits to 5-year deal for the research service

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI has signed a 5-year agreement for SciFinder from CAS, a division of the American Chemical Society (ACS). This investment ensures that all AMRI researchers globally will continue to have access to SciFinder. SciFinder gives AMRI’s research team unlimited access to a CAS’ collection of scientific content, curated by CAS scientists.   “SciFinder is an important tool for our researchers, providing ready access to scientific literature necessary for us to conduct our R&D activi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters